What’s Next in High-Protein Products? Signals from Latest Innovations
CRISPR-modified fermentation strains claiming 60–70% reductions in substrate costs are appearing in the patent record. If those claims hold at scale, the cost assumptions underpinning most alternative-protein business cases become obsolete faster than most R&D roadmaps anticipate. Whereas the industry has found the solution to hit high-protein claims of 20g-30g per serving. We analyzed high-protein […]
